Technical Analysis for SBTX - Silverback Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 48.32 -2.93% -1.46
SBTX closed down 2.93 percent on Friday, January 15, 2021, on 41 percent of normal volume. The bulls were able to push the stock to a new 52-week high. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A N/A Up
Historical SBTX trend table...

Date Alert Name Type % Chg
Shooting Star Candlestick Bearish 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Weak + Overbought Other 0.00%
Wide Bands Range Expansion 0.00%
Weak, Overbought and Reversal Signs Reversal 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish -2.93%
Older End-of-Day Signals for SBTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 9 hours ago
Down 1% about 9 hours ago
Reversed from Up about 10 hours ago
60 Minute Opening Range Breakdown about 10 hours ago
Up 1 ATR about 11 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Silverback Therapeutics, Inc. Description

Silverback Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Its lead product candidate is SBT6050, which is in a Phase I/Ib clinical trial, a TLR8 agonist linker-payload conjugated to a HER2-directed monoclonal antibody that targets tumors, such as breast, gastric, and non-small cell lung cancers. The company also focuses on developing SBT6290, a product candidate that is in preclinical stage, which is a TLR8 linker-payload conjugated to a monoclonal antibody that targets Nectin4, which is expressed in bladder, triple negative breast, head and neck, and non-small cell lung cancers. In addition, it engages in developing SBT8230, a TLR8 linker-payload conjugated to an ASGR1 monoclonal antibody that is under development for the treatment of chronic hepatitis B virus infection; and agents that localize therapies to modulate pathways in additional oncology and fibrosis indications using TLR8 and other linker-payloads. Silverback Therapeutics, Inc. was founded in 2016 and is headquartered in Seattle, Washington.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Life Sciences Clinical Medicine Immunology Drugs Treatment Of Cancer Monoclonal Antibody Small Cell Lung Cancer Antibody Hepatitis B Antineoplastic Drugs Tumors Targeted Therapy Serious Diseases Her2 Hepatitis B Virus Fibrosis Linker Lung Cancers Viral Infection Small Cell Lung Cancers Viral Infections Chronic Hepatitis B Virus Hepatitis B Virus Infection Non Small Cell Lung Cancers Tlr8

Is SBTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 54.41
52 Week Low 24.22
Average Volume 241,578
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 39.52
10-Day Moving Average 43.05
Average True Range 4.42
ADX 44.58
+DI 36.57
-DI 9.36
Chandelier Exit (Long, 3 ATRs ) 41.14
Chandelier Exit (Short, 3 ATRs ) 42.28
Upper Bollinger Band 50.77
Lower Bollinger Band 28.27
Percent B (%b) 0.89
BandWidth 56.93
MACD Line 4.94
MACD Signal Line 3.99
MACD Histogram 0.9521
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 57.64
Resistance 3 (R3) 58.63 56.52 56.08
Resistance 2 (R2) 56.52 54.15 56.02 55.56
Resistance 1 (R1) 52.42 52.68 51.37 51.43 55.05
Pivot Point 50.31 50.31 49.78 49.81 50.31
Support 1 (S1) 46.21 47.94 45.16 45.22 41.59
Support 2 (S2) 44.10 46.47 43.60 41.08
Support 3 (S3) 40.00 44.10 40.56
Support 4 (S4) 39.01